Chemical Component Summary | |
---|---|
Name | N-ACETYL-L-CYSTEINE |
Identifiers | (2R)-2-acetamido-3-sulfanyl-propanoic acid |
Formula | C5 H9 N O3 S |
Molecular Weight | 163.19 |
Type | peptide-like |
Isomeric SMILES | CC(=O)N[C@@H](CS)C(O)=O |
InChI | InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1 |
InChIKey | PWKSKIMOESPYIA-BYPYZUCNSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 19 |
Chiral Atom Count | 1 |
Chiral Atoms | CA |
Bond Count | 18 |
Aromatic Bond Count | 0 |
Leaving Atoms | OXT, H2, HXT |
Drug Info: DrugBank
DrugBank ID | DB05436 Different stereochemistry |
---|---|
Name | RK-0202 |
Groups | investigational |
Description | A substance that is being studied in the prevention of oral mucositis in patients receiving radiation therapy or chemotherapy for head and neck cancer. It is an oral polymer matrix-based rinse formulation that contains N-acetylcysteine, an antioxidant amino acid derivative with antiinflammatory properties. |
Indication | Investigated for use/treatment in adverse effects (chemotherapy). |
Mechanism of action | RK-0202, an oral rinse for the prevention and treatment of mucositis, is based on the company's ProGelz technology and is comprised of the potent antioxidant N-acetylcysteine in a polymer matrix. |